- Telehealth Visits
- Insurance plan information
Ilya Likhterov, MD
He | Him | HisHead and Neck Surgery • Head and Neck Surgical Oncology- Telehealth Visits
- Insurance plan information
Ilya Likhterov, MD
He | Him | HisHead and Neck Surgery • Head and Neck Surgical Oncology- Telehealth Visits
- Insurance plan information
On this page
About me
Dr. llya Likhterov is a surgeon who cares for patients with cancerous and noncancerous tumors of the head and neck, including those of the thyroid and parathyroid glands, salivary glands and other parts of the oral cavity, oropharynx (middle part of the throat), larynx (also known as the voice box) and skin. He has expertise in head and neck reconstructive surgery using microvascular free flap techniques, which restore function by transferring tissue and blood vessels from a healthy body area to the area needing repair.
Likhterov earned his medical degree from Weill Cornell Medical College. He completed a residency in otolaryngology – head and neck surgery at UCSF, followed by a fellowship in head and neck and microvascular surgery at Mount Sinai Beth Israel.
Education & training
Board certification
- Otolaryngology - Head & Neck Surgery, American Board of Otolaryngology
Fellowship
- Head and Neck Oncologic and Reconstructive Surgery, Mount Sinai Beth Israel
Residency
- Otolaryngology-Head and Neck Surgery, UCSF Graduate Medical Education
Degree
- MD, Weill Cornell Graduate School of Medical Sciences
My expertise
Locations
Clinical Trials query: q=health_gateway_id_ss%3A%28%221604%22%29+AND+status_s%3A%28%22Recruiting%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Clinical+Trial%22
Puiblications query: q=health_gateway_id_ss%3A%28%221604%22%29&rows=4&sort=date_published+desc&fq=content_type%3A%22Publication%22
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here. The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.